title: Evidence that the immunopathogenic mechanism of lithium-induced psoriasis differs from that of regular psoriasis.
authors: Esther M
authors: EM
authors: Knijff
authors: Ralph W
authors: RW
authors: Kupka
authors: Cindy
authors: C
authors: Ruwhof
authors: M Nadine
authors: MN
authors: Breunis
authors: Errol P
authors: EP
authors: Prens
authors: Willem A
authors: WA
authors: Nolen
authors: Hemmo A
authors: HA
authors: Drexhage
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007375:Interleukin-1 / Q000378:metabolism*; D015850:Interleukin-6 / Q000378:metabolism*; D018021:Lithium Chloride / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000139:chemically induced* / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D014150:Antipsychotic Agents; D007375:Interleukin-1; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D018021:Lithium Chloride